Why Did Medical Marijuana Become Illegal and Why Is It Now Become Legal Again

MEDICAL-USE UPDATE: Equally of Feb 3, 2022 37 states, iv territories and the District of Columbia allow the medical use of cannabis products.
In Nov 2020, voters in Mississippi passed a ballot initiative to allow for medical utilise, just it was overturned by the state supreme court on May 14, 2021. The legislature passed new legislation which was signed by the governor Feb. 2, 2022. See Table 1 below.

NON MEDICAL/ADULT-USE UPDATE: As of November 29, 2021, 18 states, 2 territories and the District of Columbia have enacted measures to regulate cannabis for adult non medical use.

• Voters in Arizona, Montana, New Jersey and South Dakota approved measures to regulate cannabis for non medical employ.
• On Feb. eight, 2021, Southward Dakota Circuit Judge Christina Klinger ruled that the measure was unconstitutional. The South Dakota Supreme Court upheld this decision on November 24, 2021 by a vote of 4-ane.
• New Jersey's governor signed enacting legislation on March ane, 2021.
• New York'south legislature and governor enacted AB 1248/SB 854 on March 31, 2021.
• The Virginia General Assembly passed legislation on February. 27 and canonical the governor'due south amendments on Apr 7, 2021.
• The New Mexico legislature passed legislation on March 31 and the governor signed it on April 12, 2021.
• The Connecticut General Assembly passed SB 1201 on June 17 and the governor signed it on June 22, 2021.
• These actions bring the number of states with not medical (adult-employ) regulated cannabis to 18, plus two territories and the District of Columbia (D.C. does not regulate non medical sales).
• This total does Non include South Dakota's court-over-turned measure.

Please see Table 1 below for more information.

A total of 37 states, the District of Columbia, Guam, Puerto Rico and the U.S. Virgin Islands regulate cannabis for medical use by qualified individuals.
Please see Table 1 beneath for more information.

Approved measures in 11 states allow the apply of "depression THC, loftier cannabidiol (CBD)" products for medical reasons in limited situations or equally a legal defense. (See Table ii below for more information). Depression-THC programs are non counted as comprehensive medical cannabis programs. NCSL uses criteria similar to other organizations tracking this event to determine if a plan is "comprehensive":

1. Protection from criminal penalties for using cannabis for a medical purpose.
2. Admission to cannabis through dwelling cultivation, dispensaries or some other system that is likely to be implemented.
3. It allows a variety of strains or products, including those with more than than "low THC."
4. Information technology allows either smoking or vaporization of some kind of cannabis products, establish material or excerpt.
5. Is non a limited trial program. (Nebraska has a trial program that is non open up to the public.)

* = Measures canonical past voters in Mississippi for medical use and South Dakota for non medical use were overturned in 2021. The Mississippi legislature passed new medical cannabis legislation which the governor signed on Feb. 2, 2022.
Please run into Table ane below for more than data.

Medical Uses of Cannabis

In response to California's Prop 215, the Institute of Medicine issued a report that examined potential therapeutic uses for cannabis. The report found that: "Scientific data signal the potential therapeutic value of cannabinoid drugs, primarily THC, for hurting relief, control of nausea and airsickness, and ambition stimulation; smoked marijuana, however, is a crude THC delivery system that likewise delivers harmful substances. The psychological effects of cannabinoids, such as anxiety reduction, sedation, and euphoria can influence their potential therapeutic value. Those effects are potentially undesirable for certain patients and situations and benign for others. In addition, psychological furnishings tin complicate the interpretation of other aspects of the drug's effect."

Further studies have found that marijuana is effective in relieving some of the symptoms of HIV/AIDS, cancer, glaucoma, and multiple sclerosis.¹

In early 2017, the National Academies of Sciences, Engineering, and Medicine released a report based on the review of over 10,000 scientific abstracts from cannabis health enquiry. They too made 100 conclusions related to health and suggest ways to improve cannabis enquiry.

Land vs Federal Perspective

At the federal level, cannabis remains classified as a Schedule I substance under the Controlled Substances Act, where Schedule I substances are considered to have a high potential for dependency and no accepted medical use, making distribution of cannabis a federal offense. In October of 2009, the Obama Administration sent a memo to federal prosecutors encouraging them not to prosecute people who distribute cannabis for medical purposes in accordance with state law.

In late August 2013, the U.S. Department of Justice announced an update to their marijuana enforcement policy. The argument read that while cannabis remains illegal federally, the USDOJ expects states like Colorado and Washington to create "strong, state-based enforcement efforts.... and will defer the correct to claiming their legalization laws at this time." The section also reserves the correct to challenge the states at any time they feel it'southward necessary.

More than recently, in January 2018, erstwhile Attorney General Sessions issued a Marijuana Enforcement Memorandum that rescinded the Cole Memorandum, and allows federal prosecutors to decide how to prioritize enforcement of federal cannabis laws. Specifically, the Sessions memorandum directs U.S. Attorneys to "weigh all relevant considerations, including federal law enforcement priorities set by the Attorney General, the seriousness of the crime, the deterrent issue of criminal prosecution, and the cumulative impact of particular crimes on the community." Text of the memo can be found hither: https://world wide web.justice.gov/opa/pr/justice-department-issues-memo-marijuana-enforcement

NCSL's policy on state cannabis laws can be found under Additional Resources below.

Arizona and the District of Columbia voters passed initiatives to let for medical use, only to have them overturned. In 1998, voters in the District of Columbia passed Initiative 59. All the same, Congress blocked the initiative from becoming law. In 2009, Congress reversed its previous conclusion, assuasive the initiative to become law. The D.C. Council then put Initiative 59 on hold temporarily and unanimously canonical modifications to the law.

Before passing Proffer 203 in 2010, Arizona voters originally passed a ballot initiative in 1996. However, the initiative stated that doctors would be allowed to write a "prescription" for cannabis. Since cannabis is a Schedule I substance, federal law prohibits its prescription, making the initiative invalid. Medical cannabis "prescriptions" are more often called "recommendations" or "referrals" because of the federal prescription prohibition.

States with medical cannabis laws generally have some form of patient registry, which may provide some protection against arrest for possession up to a certain amount of products for personal medicinal use.

Some of the most mutual policy questions regarding medical cannabis include how to regulate its recommendation, dispensing, and registration of canonical patients. Some modest cannabis growers or are ofttimes chosen "caregivers" and may grow a certain number of plants per patient. This result may also be regulated on a local level, in addition to whatsoever country regulation.

Table ane. Land Medical Marijuana/Cannabis Program Laws

Land (click state name to spring to program information)	Statutory Language (yr	Patient Registry or ID cards	Allows Dispensaries	Specifies Weather	Recognizes Patients from other states	State Allows for Retail Sales/Not Medical Adult Employ
Alabama	SB46 (2021)	Aye	Yeah	Yes	No
Alaska	Measure 8 (1998) SB 94 (1999) Statute Title 17, Chapter 37	Yes	Yes	Yes	No, only adults 21 and older may purchase at not medical retail dispensaries.	Ballot Measure two (2014) Marijuana Regulations
Arizona	Proposition 203 (2010)	Yes	Yeah	Yes	Yes, for AZ-approved atmospheric condition, but non for dispensary purchases.	Proposition 207 (2020)
Arkansas	Upshot half-dozen (2016)	Yes	Yeah	Yes	Yes
California	Proffer 215 (1996)  SB 420 (2003)	Yeah	Yes (cooperatives and collectives)	No	No	Proposition 64 (2016)
Colorado Medical programme info -Non medical use info	Amendment 20 (2000)	Aye	Yep	Yes	No	Subpoena 64 (2012) Chore Strength Implementation Recommendations (2013) Analysis of CO Subpoena 64 (2013) Colorado Marijuana Sales and Tax Reports 2014 "Edibles" regulation measure FAQ about CO cannabis laws by the Denver Mail service.
Connecticut	HB 5389 (2012) Not medical use legislation SB 1201 (2021)	Yes	Yes	Yes		SB 1201 (2021)
Delaware	SB 17 (2011)	Yes	Yes	Aye	Aye, for DE-approved conditions.
District of Columbia	Initiative 59 (Passed by voters only blocked by the Barr Subpoena in 1998) L18-0210 or Human action B18-622 (2010)	Yes	Yes	Yes		Initiative 71 (2014)
Florida	Subpoena two (2016)	Yes	Yes	Yes	No
Guam	Proposal 14A  Canonical in Nov. 2014, fully operational.- home growing allowed. Non medical adult use- 2019 Bill No. 32-35 signed by governor in April, 2019	Yeah	Yeah	Yes	No	Yes. Non medical use- 2019 Bill No. 32-35 signed by governor in April, 2019
Hawaii	SB 862 (2000)	Yep	Yes	Yes	No
Illinois	HB ane (2013)Eff. 1/1/2014 Rules Non medical utilise legalization SB 0007 bill passed legislature May, 2019, signed past governor June 25, 2019, Effective Jan. 1, 2020.	Yep	Yeah	Yes	No	Measure approved by legislature in May, 2019, signed by governor June 25, 2019. Effective Jan. 1, 2020.
Louisiana	SB 271 (2017) (not even so in effect)	No	Aye	Yep	No
Maine	Question 2 (1999)  LD 611 (2002)   Question five (2009)   LD 1811 (2010) LD 1296 (2011)	Aye	Yes	Yes	Yes, but non for dispensary purchases. Adults 21 and older may purchase from non medical retail dispensaries.	Question 1 (2016) page four Chapter 409 (2018)
Maryland	HB 702 (2003) SB 308 (2011) HB 180/SB 580 (2013)  HB 1101- Chapter 403 (2013) SB 923 (signed 4/14/14) HB 881- similar to SB 923	Yes	Yeah	Yeah	No
Massachusetts	Question 3 (2012) Regulations (2013)	Yes	Yeah	Yes	No	Question 4 (2016)
Michigan	Proposal 1 (2008)	Yes	Yes	Yes	Yes, for legal protection of possession, only not for clinic purchases. Adults 21 and older may purchase from non medical retail dispensaries.	Proposal 18-1 (2018)
Minnesota	SF 2471, Chapter 311 (2014)	Yeah	Yes, express, liquid extract products only	Aye	No
Mississippi *overturned May 14, 2021	SB 2095 (2022) Initiative 65 (2020)* News: Mississippi Supreme Court Overturns Medical Marijuana Amendment 65	Yes Yeah	Yes Aye	Yes Yes	Yes- must apply to MDOH. Yet to be adamant
Missouri	Amendment 2 (2018)	Yes	Yep	Yes	Yes
Montana	Initiative 148 (2004) SB 423 (2011) Initiative 182 (2016)	Yeah Yes	Aye  Yes	Yes   Yes	No	Initiative 190 (2020)
Nevada	Question ix (2000) NRS 453A NAC 453A	Yes	Yes	Yes	Yes, if the other state's plan are "substantially similar." Patients must fill out Nevada paperwork. Adults 21 and older may purchase at not medical retail dispensaries.	Question 2 (2016) page 25
New Hampshire	HB 573 (2013) HB 89 (2021)	Yes	Aye	Yes	Yeah, with a note from their home state, but they cannot purchase through dispensaries.
New Jersey	SB 119 (2009) Program information	Yeah	Aye	Yes	No	Public Question one passed by voters in 2020 to allow legislature to enact legislation NJ AB 21 passed legislature, signed by governor March 1, 2021
New United mexican states	SB 523 (2007) Medical Cannabis Program	Yep	Aye	Yes	No	HB 2 Cannabis regulation human activity passed legislature March 31, 2021 and signed by governor on 4/12/21.
New York	A6357 (2014) Signed by governor 7/5/fourteen	Yeah	Yep- Ingested doses may not contain more than than x mg of THC, product may not be combusted (smoked).	Yes	No	AB 1248A/SB 854 passed legislature, signed past governor on March 31, 2021.
North Dakota	Measure 5 (2016) NDCC 19-24.ane NDAC 33-44	Yes	Yes	Yep	No
Northern Mariana Islands	Does non take a medical program.					Yes, HB 20-178 HD four- Public Law 20-66 (2018)
Ohio	HB 523 (2016) Approved by legislature, signed by governor 6/8/16	Yes	Aye	Yeah	Aye- If canonical by the Board of Chemist's on a state-by-state ground.
Oklahoma	SQ 788 Canonical past voters on 6/26/eighteen	Aye	Yes	Yes, but list was not included in the initial ballot measure.	Yes but must utilize equally a temporary patient
Oregon	Oregon Medical Marijuana Act (1998) SB 161 (2007)	Yes	Yes	Yeah	No, but adults over 21 may purchase at adult retail dispensaries.	Measure out 91 (2014)
Pennsylvania	SB 3 (2016) Signed past governor 4/17/16	Yes	Aye	Yeah	No
Puerto Rico	Public Health Department Regulation 155 (2016) in Spanish	Yes	Yes- Cannot be smoked	Yes	Yeah
Rhode Island	S 710 B (2006)- Legislature overturned governor'southward veto. SB 791 (2007)  SB 185 (2009)	Yes	Aye	Yes	Yep
S Dakota *Non medical employ mensurate ruled unconstitutional equally of February. 9, 2021.	Initiated Measure 26 (2020) News: Court rules measure unconstitutional Feb. eight, 2021 News: AG volition not entreatment courtroom decision Feb. 12, 2021 News: Legislature considering legislation Feb. 9, 2021	Yep	Yeah	Yes	Nevertheless to be determined	Amendment A (2020) OVERTURNED BY COURTS Feb. 8, 2021 Not COUNTED IN Land TALLY To a higher place
United states Virgin Islands	SB 135 (2017) signed by governor 1/19/19
Utah	Prop 2 (2018) replaced by HB 3001 HB 3001 2018- Third Special Session	Yeah	Yes	Yes	Yes
Vermont	SB 76 (2004) SB vii (2007) SB 17 (2011) H.511 (2018)	Yes	Yep	Yes	No, simply adults 21 years old and older may buy from the not medical market.	H.511 approved by legislature, signed by governor ane/22/18. Effective July 1, 2018. S.54 (2020) establishes sales regulations. Effective Oct. 7, 2020. Governor's letter of the alphabet re: S. 54, going into effect without his signature.    Additional info: Governor's Marijuana Advisory Commission Concluding Report- December, 2018
Virginia	H 1460 (2020) S 646 (2020) H 1617 (2020) S 976 (2020) Legislative Timeline (2020) Board of Chemist's overview Board of Chemist's shop FAQ	Yes	Yeah	No	No, but allows for temporary residents to use with approval from the Lath of Pharmacy.	Yes, legislature approved HB2312 and SB1406.Signed by governor four/7/21.
Washington	Initiative 692(1998) SB 5798 (2010) SB 5073 (2011)	Registry is voluntary.	Yeah, canonical as of Nov. 2012, stores opened in July, 2014.	Yes	No, but adults 21 and older may purchase at non medical retail dispensaries.	Initiative 502 (2012) WAC Marijuana rules: Chapter 314-55 WAC FAQ about WA cannabis laws by the Seattle Times.
West Virginia	SB 386 (2017)	Yes	Yeah. No whole bloom/cannot be smoked just can exist vaporized.	Yes	No, only may permit their patients who are terminally ill to buy in other states. WV does not recognize other state cards.

*The links and resources are provided for information purposes just. NCSL does non endorse the views expressed in whatsoever of the manufactures linked from this page.

Tabular array 2. Express Access Cannabis Product Laws (low THC/loftier CBD- cannabidiol)

Land	Program Name and Statutory Linguistic communication (year)	Patient Registry or ID cards	Dispensaries or Source of Product(s)	Specifies Conditions	Recognizes Patients from other states	Definition of Products Immune	Allows for Legal Defense force	Allowed for Minors
Alabama (SB46 of 2021 created a new medical cannabis law enacted on May 17, 2021 and is listed in Table 1.)	SB 174 "Carly's Law" (Human action 2014-277) Allows University of Alabama Birmingham to conduct effectiveness research using low-THC products for treating seizure disorders for up to 5 years.  HB 61 (2016) Leni'south Law allows more than physicians to refer patients to utilize CBD for more than conditions.	No	Provides legal defense force for possession and/or utilize of CBD oil.  Does not create an in-state production method.	Yes, debilitating epileptic weather, life-threatening seizures, wasting syndrome, chronic hurting, nausea, muscle spasms, any other sever condition resistant to conventional medicine.	No	Extracts that are depression THC= below iii% THC	Yep	Yes
Florida (NEW comprehensive program approved in 2016, included in tabular array above)	Empathetic Medical Cannabis Act of 2014 CS for SB 1030 (2014) Patient treatment information and outcomes will be collected and used for intractable babyhood epilepsy research	Yes	Yep, 5 registered nurseries across the land by region, which accept been in business at least 30 years in Florida.	Yeah, cancer, medical condition or seizure disorders that chronically produces symptoms that can be alleviated past depression-THC products	No	Cannabis with low THC= below .8% THC and above ten% CBD by weight		Yeah, with approving from 2 doctors
Georgia	HB 1 (2015) (signed by governor 4/16/15)	Yes	Law allows Academy Organization of Georgia to develop a lot THC oil clinical enquiry program that meets FDA trial compliance.	Yeah, end stage cancer, ALS, MS, seizure disorders, Crohn'due south, mitochondrial disease, Parkinson's, Sickle Cell disease	No	Cannabis oils with low THC= beneath v% THC and at least an equal corporeality of CDB.	Aye	Yes
Idaho- VETOED BY GOVERNOR	SB 1146(VETOED by governor four/16/15)	No	Doesn't define.	The possessor has, or is a parent or guardian of a person that has, cancer, amyotrophic lateral sclerosis, seizure disorders, multiple sclerosis, Crohn's illness, mitochondrial affliction, fibromyalgia, Parkinson's disease or sickle cell disease;	No	Is composed of no more than iii-tenths percent (0.3%)  tetrahydrocannabidiol by weight;  is composed of at least xv (xv) times more cannabidiol than tetrahydrocannabidiol by weight; and contains no other psychoactive substance.	Yep	Yeah
Indiana	HB 1148 (2017)	Yes	Doesn't ascertain.	Treatment resistant epilepsy.	No	At least 5 percentage CBD by weight. No more than than .iii per centum THC by weight.	Yes	Yes
Iowa	SF 2360, Medical Cannabidiol Act of 2014 (Effective 7/1/xiv and repealed in 2017 and replaced) HF 524 of 2017 now Section 124E	Yes	Yes	Yes	Yes, for possession or utilise just, not for purchasing CBD in Iowa.	Less than 3 percent THC	Yes	Yes
Kentucky	SB 124 (2014) Clara Madeline Gilliam Human activity Exempt cannabidiol from the definition of marijuana and allows information technology to be administered past a public university or school of medicine in Kentucky for clinical trial or expanded access program approved by the FDA.	No	Universities in Kentucky with medical schools that are able to get a research trial. Doesn't allow for in-state production of CBD production.	Intractable seizure disorders	No	No, merely "cannabidiol".
Mississippi (Overturned Subpoena 65 from 2020 included in tabular array higher up.)	HB 1231 "Harper Grace's Law" 2014		All provided through National Eye for Natural Products Research at the Univ. of Mississippi and dispensed by the Dept. of Chemist's shop Services at the Univ. of Mississippi Medical Centre	Yep, debilitating epileptic condition or related disease	No	"CBD oil" - processed cannabis plant extract, oil or resin that contains more than than 15% cannabidiol, or a dilution of the resin that contains at least l milligrams of cannabidiol (CBD) per milliliter, but non more than i-one-half of i percent (0.5%) of tetrahydrocannabinol (THC)	Yes, if an authorized patient or guardian	Yes
Missouri (NEW comprehensive plan approved in 2018, included in table above)	HB 2238 (2014)	Yes	Yes, creates cannabidiol oil care centers and cultivation and production facilities/laboratories.	Yes, intractable epilepsy that has not responded to three or more than other treatment options.	No	"Hemp extracts" equal or less than .3% THC and at least 5% CBD by weight.	Aye	Yes
North Carolina	HB 1220 (2014) Epilepsy Alternative Treatment Deed- Pilot Written report HB 766 (2015) Removes Pilot Study designation	Yes	University research studies with a hemp extract registration card from the state DHHS or obtained from another jurisdiction that allows removal of the products from the country.	Yes, intractable epilepsy	No	"Hemp extracts" with less than nine-tenths of ane pct (0.9%) tetrahydrocannabinol (THC) by weight. Is equanimous of at to the lowest degree five percent (5%) cannabidiol by weight. Contains no other psychoactive substance.	Yes	Yes
Oklahoma (NEW comprehensive medical plan approved in 2018 and listed above)	HB 2154 (2015)	Aye	No in-state production allowed, so products would have to be brought in. Any formal distribution organisation would require federal approval.	People nether 18 (minors) Minors with Lennox-Gastaut Syndrome, Dravet Syndrome, or other severe epilepsy that is not adequately treated past traditional medical therapies	No	A preparation of cannabis with no more than .three% THC in liquid form.	Yeah	Yes, only allowed for minors
South Carolina	SB 1035 (2014) Medical Cannabis Therapeutic Treatment Act- Julian's Law	Yes	Must use CBD product from an approved source; and (2)    approved by the United States Food and Drug Administration to be used for treatment of a condition specified in an investigational new drug application. -The principal investigator and any subinvestigator may receive cannabidiol straight from an approved source or authorized distributor for an approved source for use in the expanded admission clinical trials. Some have interpreted the law to allow patients and caregivers to produce their own products.	Lennox-Gastaut Syndrome, Dravet Syndrome, likewise known every bit severe myoclonic epilepsy of infancy, or any other form of refractory epilepsy that is non adequately treated by traditional medical therapies.	No	Cannabidiol or derivative of marijuana that contains 0.9% THC and over xv% CBD, or least 98 percent cannabidiol (CBD) and not more than 0.90% tetrahydrocannabinol (THC) by book that has been extracted from marijuana or synthesized in a laboratory	Yes	Yes
Tennessee	SB 2531 (2014) Creates a four-year study of high CBD/low THC cannabis at Tenn. Tech Univ.	Researchers need to runway patient information and outcomes	Only products produced by Tennessee Tech University. Patients may possess depression THC oils simply if they are purchased "legally in the United States and outside of Tennessee," from an assumed medical cannabis land, however near states do not let products to leave the state.	Yes, intractable seizure conditions.	No	"Cannabis oil" with less than .nine% THC as role of a clinical research written report.	Yes	Aye
	HB 197 (2015)	No	Allows for legal defence force for having the product as long as it was obtained legally in the US or other medical cannabis state.	Yeah, intractable seizure conditions.	No	Aforementioned as above.	Yes	Yes
Texas	SB 339 (2015) Texas Compassionate Utilise Human action HB 3703 (2019)	Yes	Yeah, licensed by the Section of Public Safe.	Yes, intractable epilepsy, incurable neurodegenerative disease, last cancer, multiple sclerosis, spasticity, ALS, autism.	No	"Low-THC Cannabis" with not more than than 0.five percent by weight of tetrahydrocannabinols.	Yes	Yeah
Utah (NEW comprehensive program approved in 2018, included in table in a higher place)	HB 105 (2014) Hemp Extract Registration Act	Yes	Not completely clear, withal information technology may allow higher education institutions to abound or cultivate industrial hemp.	Yes, intractable epilepsy that hasn't responded to iii or more treatment options suggested by a neurologist.	No	"Hemp extracts" with less than .iii% THC by weight and at least fifteen% CBD by weight and contains no other psychoactive substances	Yes	Yes
Virginia (NEW comprehensive medical programme approved in 2020 and listed to a higher place)	HB 1445- no longer in outcome	No	No in-state means of acquiring cannabis products.	Intractable epilepsy	No	Cannabis oils with at to the lowest degree 15% CBD or THC-A and no more than five% THC.	Yep	Yes
Wisconsin	AB 726 (2013 Deed 267)	No	Physicians and pharmacies with an investigational drug permit by the FDA could dispense cannabidiol. Qualified patients would too be immune to access CBD from an out-of-state medical cannabis dispensary that allows for out-of-state patients to use their dispensaries too equally remove the products from the state. No in-state production/manufacturing mechanism provided.	Seizure disorders		Exception to the definition of prohibited THC by state law, allows for possession of "cannabidiol in a course without a psychoactive effect."  THC or CBD levels are not defined.	No	Yes
Wyoming	HB 32 (2015) Supervised medical employ of hemp extracts. Effective 7/one/2015	Yeah	No in-state production or buy method defined.	Intractable epilepsy or seizure disorders	No	"Hemp extracts" with less than 0.3% THC and at least five% CBD by weight.	Yes	Yes

*The links and resources are provided for information purposes only. NCSL does not endorse the views expressed in any of the articles linked from this page.

Boosted Resource

• NCSL's Cannabis & Employment Laws page.
• NCSL's Marijuana Deep Dive folio featuring marijuana and cannabis laws on criminal justice, health and other resources.
• NCSL FY 2018 letter the LCJPS Committee sent to the Hill  opposing the withholding of funding for state with medical marijuana laws:

  NCSL FY 2018 CJS Appropriations Back up Letter. (May xvi, 2017)

• State Marijuana Policy covered in Episode four of NCSL'south podcast, Our American States.
  You can observe information technology on our website or subscribe to the podcast in iTunes, Google Play or your favorite podcast app.

• Comparisons of programs
  • Comparison of all state medical marijuana programs with contact information. Prepared past the Network for Public Health Law equally of February. 2019
  • Comparison of state limited access medical marijuana programs. Prepared past the Network for Public Health Law equally of June 2018.
  • "State-past-Country Medical Marijuana Laws" Marijuana Policy Project, 2019
• Finances/Taxation data
  • Regulating Marijuana: Taxes, Banking and Federal Laws, Nov 2015
  • "State Medical Marijuana Programs' Financial Information," Marijuana Policy Project, July 2015
  • "Medical Marijuana Dispensary Laws: Fees and Taxes," Marijuana Policy Project
  • Colorado Marijuana Sales and Tax Reports (updated monthly)
  • Washington Land Sales and Tax Information (updated weekly)
  • "Taxing Marijuana: The Washington and Colorado Experience," Tax Foundation, August 2014
• Law enforcement/crime data
  • "What Law Enforcement Can Larn from Marijuana Legalization in Colorado," Prepared by American War machine University, March, 2015
  • Statement by ONDCP Manager Gil Kerlikowske regarding Federal guidelines for medical marijuana prosecution
• Medical marijuana research and reports
  • The Wellness Effects of Cannabis and Cannabinoids: The Electric current State of Bear witness and Recommendations for Research, 2017
  • "Marijuana and Medicine: Assessing the Science Base," Found of Medicine, 1999
  • "Exposing the Myth of Smoked Medical Marijuana," U.Southward. Drug Enforcement Administration
  • Treatment Research Institute'due south (TRI) policy position statement regarding medical marijuana
  • ProCon.org's resources on medical marijuana. Medical Marijuana ProCon.org presents laws, studies, statistics, surveys, government reports, and pro and con statements on questions related to marijuana as medicine
  • "Condign a Country-Authorized Patient," Americans for Safe Access
• Non medical/Adult Utilise information and news
  • Regulating Marijuana: Taxes, Banking and Federal Laws, November 2015
  • Regulating Marijuana: A Twelvemonth and a Half In, NCSL, October 2015
  • "Land Legalization of Recreational Marijuana: Selected Legal Issues." Congressional Research Service, April 2013
  • Analysis of CO Subpoena 64 (rec use initiative) by Colorado State University, Apr 2013
  • Colorado Marijuana Sales and Tax Reports
  • Colorado Marijuana Enforcement Segmentation Annual Update, February 2015
  • Public Wellness Law Enquiry Constabulary Atlas: Recreational Marijuana Laws - Interactive Map
• Public health and youth information
  • Marijuana Joins Fume-Gratis Laws, State Legislatures, March 2013
  • Regulating Recreational Use of Marijuana and the Office of Public Wellness Law Prepared by the Network for Public Wellness Law
  • Marijuana Bear upon on Public Health and Safe in Colorado: conference by CO Association of Chiefs of Police, Jan fourteen-16, 2015
  • Smart Colorado: Protecting youth from marijuana
• Interest groups, position statements, opinions, and model regulation examples
  • SAM: Smart Approaches to Marijuana
  • Smart Colorado: Protecting youth from marijuana
  • Resource from the Public Health Institute
  • Treatment Research Institute's (TRI) policy position argument regarding medical marijuana
  • National Families in Action: Marijuana Studies Programme "Marijuana Report"
  • "Medical Cannabis as a Tool to Combat Pain and the Opioid Crunch: A Pattern for State Policy" Americans for Safe Access
  • "State-by-State Medical Marijuana Laws" Marijuana Policy Project, 2016
  • "Primal Aspects of Land and DC Medical Marijuana Laws," Marijuana Policy ProjectSave
  • "Condign a State-Authorized Patient," Americans for Rubber Access
  • Brookings Institution: Colorado's Rollout of Legal Marijuana Is Succeeding

soileaushisher.blogspot.com

Source: https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx